The metalloproteins specialist Forge Therapeutics and Active Motif, which develops tools to help "turn off" certain genes, have penned a new deal in epigenetic research. The two biotech ...
insights from industryDr. Kathyrn CunninghamProduct ManagerActive Motif An interview with Dr. Kathyrn Cunningham from Active Motif at SfN 2018, discussing the importance of epigenetics and overcoming ...
Forge Therapeutics and Active Motif said today they will partner on epigenetic research related to the family of iron-containing lysine demethylases known as Jumonji KDMs. The research ...
AKS2 will be used to aid pharmacogenomic-based research. Translational Genomics Research Institute (TGen) licensed Active Motif’s data mining software. It will use AKS2, or almaKnowledgeServer™, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback